WNT5A and ovarian cancer: Moreover, ovarian cancer cell lines, characterized by high levels of Wnt5a expression, have shown lower sensitivity to several drugs (paclitaxel, oxaliplatin, 5-FU, epirubicin, and etoposide) [74,75].